September 15, 2019
Phase III Trial of Stage I Ovarian Cancer After Surgery
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
BAY43-9006 Phase II Study for Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Read More
January 30, 2019
Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Read More
January 30, 2019
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
Read More
January 30, 2019
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
Read More
January 30, 2019
Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Read More
December 10, 2018
A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn’s Disease
Read More
Load More
X